v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 20,721 $ 28,647
Short-term investments 21,943 17,984
Accounts receivable, net 89,571 89,587
Inventory, net 90,585 92,746
Prepaid expenses and other current assets 7,025 9,102
Total current assets 229,845 238,066
Property and equipment, net 11,814 12,403
Right-of-use lease assets 5,596 0
Other assets 5,007 5,408
Total assets 252,262 255,877
Current liabilities:    
Accounts payable 11,641 8,994
Accrued clinical and manufacturing liabilities 22,178 26,597
Accrued payroll and employee liabilities 6,632 9,270
Other accrued liabilities 51,494 51,237
Current lease liabilities 200 0
Total current liabilities 92,145 96,098
Non-current notes payable, net 108,725 107,899
Non-current convertible notes payable, net 33,925 32,739
Non-current lease liability 5,504 0
Other non-current liabilities 5,055 4,808
Total liabilities 245,354 241,544
Stockholders' equity:    
Common stock 1,895 1,883
Series A convertible preferred stock 1,050 1,050
Additional paid-in capital 1,957,358 1,951,185
Accumulated other comprehensive (loss) income (6) 4
Accumulated deficit (1,953,389) (1,939,789)
Total stockholders' equity 6,908 14,333
Total liabilities and stockholders' equity $ 252,262 $ 255,877